A 66-Year-Old-Man with Metastatic Prostate Cancer - Episode 3

Factors for Consideration when Choosing an ADT Regimen for mCSPC

Jason Hafron, MD, revisits the patient profile and discusses factors that inform treatment decision-making in mCSPC.

EP. 1: Introduction: A 66-Year-Old-Man with Metastatic Prostate Cancer
EP. 2: Available Monotherapies and Combination Therapies in mCSPC
Now Viewing
EP. 3: Factors for Consideration when Choosing an ADT Regimen for mCSPC
EP. 4: Unmet Needs and Investigational Therapies in mCSPC